Pay in 4 interest-free payments of $5.41 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Possible side effects are not well defined because no controlled human safety trial exists
(6) The research team hypothesized that AOD 9604 possibly enhanced the doxorubicin binding to multiple breast cancer cell protein targets, thereby exhibiting greater anti-proliferative activity against the MCF-7 breast cancer cell line compared to chitosan loaded with doxorubicin alone
Table of Contents Toggle Literature Scope and Evidence Hierarchy This article is an evidence-informed narrative review rather than a systematic review or meta-analysis
The significance of this observation lies in the fact that VEGFR-2 activation is one of the primary pathways that regulate endothelial cell proliferation and the growth of new blood vessels
US$ 28.54
US$ 22.08
US$ 21.51
